EU says AstraZeneca vaccine supply is global problem, not EU-Australia issue




  • In US
  • 2021-04-07 11:18:31Z
  • By Reuters
 

BRUSSELS (Reuters) - The European Commission said on Wednesday that delivery shortfalls of AstraZeneca's COVID-19 vaccine were a global issue, not something to be addressed only in talks between the EU and Australia.

The comment followed Australia's request to the EU to send AstraZeneca doses. Canberra has said the EU has blocked shipments, whereas the EU says AstraZeneca had not requested new authorisations for exports to Australia.

"We're not the only region in the world producing AstraZeneca vaccines, and therefore this is a global issue. It is definitely not simply a bilateral issue between one country and the European Union," a spokesman for the EU Commission told a news conference when asked about Australia's request.

The spokesman said the EU was also facing huge shortfalls of AstraZeneca vaccine deliveries.

(Reporting by Francesco Guarascio @fraguarascio and John Chalmers; editing by Philip Blenkinsop)

COMMENTS

More Related News

AstraZeneca has not reacted yet to EU letter on vaccines - Corriere
AstraZeneca has not reacted yet to EU letter on vaccines - Corriere
  • US
  • 2021-04-11 14:45:47Z

AstraZeneca has yet to react to a letter sent by the European Commission to complain over below-contract supplies of COVID-19 vaccines, Italian daily...

Brazil
Brazil's virus outlook darkens amid vaccine supply snags
  • US
  • 2021-04-11 13:46:21Z

April is shaping up to be Brazil's darkest month yet in the pandemic, with hospitals struggling with a crush of patients, deaths on track for record highs...

J&J Covid Vaccine Reviewed by EU Regulator After Blood Clots
J&J Covid Vaccine Reviewed by EU Regulator After Blood Clots

(Bloomberg) -- The European Union's drug regulator has started a review to assess blood clots in people who received Johnson & Johnson's Covid-19...

Unwanted vaccines needed to help poor countries catch up, international health officials say
Unwanted vaccines needed to help poor countries catch up, international health officials say

Doses of vaccines rejected as countries fine-tune their inoculation campaigns will go to poor countries where possible to counter a "shocking imbalance" in...

European regulators are watching J&J
European regulators are watching J&J's vaccine for unusual blood clots

The European Medicines Agency is investigating reports of clots in people who received J&J's vaccine. The shot has not yet been given out in Europe.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US